Dear E,
With customization now an integral part of the virtual clinical trial development process, the ability to act nimbly with proven expertise is critical. And there's no better way to share our expertise than to show it in action.
A cutting-edge biotech was running a program with three active, concurrent, pain studies across 25 sites and 218 patients, with interim database locks scheduled during the summer of 2020 and final database lock deadlines looming close behind. In under 4 months, we were able to successfully transition three active studies, maintaining the integrity and quality of the primary endpoints without an increase in our patient dropout rate or deviation from our pre-pandemic timeline, staying true to the database lock target dates for Studies 1 and 2.
Download our case study to see how we were able to successfully adjust protocols by implementing site-specific solutions and operational efficiencies while maintaining the integrity and quality of primary endpoints. This case study outlines the implementation of the following initiatives:
- Visit Window Extensions
- Telemedicine Visits
- Contract Updates
- Remote Monitoring Visits
- EDC Migration
